摘要
利用体外培养人脐静脉内皮细胞,经不同浓度的雷公藤甲素(0、5、10、20、30μg/L)处理后,MTT法显示雷公藤甲素可抑制内皮细胞的增殖,5μg/L雷公藤甲素的抑制率达29.15%;琼脂凝胶立体细胞培养系统检测发现内皮细胞经雷公藤甲素作用后,其游走能力降低;鸡胚尿囊膜试验观察到雷公藤甲素可有效抑制血管的生成;荧光定量RT-PCR检测发现雷公藤甲素可下调内皮细胞u-PAmRNA的表达。因此认为,雷公藤甲素可能在基因水平上干扰内皮细胞u-PAmRNA的表达,减少u-PA蛋白的生成,从而有效地抑制血管内皮细胞的增殖和移行,这可能是雷公藤甲素抑制血管生成的主要机制之一。
In order to unveil the anti-angiogenic mechanism of triptolide, we investigated the effects of triptolide on the proliferation, migration, angiogenesis and u-PA expression of cultured HUVECs. MTT assay found that triptolide could inhibit the proliferation of HUVECs,and three-dimensional culture system revealed that triptolide could curb the migration of HUVECs. The chick embryo chorioallantoic membrane （CAM） test showed that triptolide could inhibit angiogenesis. Real time quantitive RT-PCR showed the expression of u-PA of HUVECs was down-regulated by triptolide. Therefore, triptolide may inhibit the proliferation and migration of endothelial cell by way of reducing the expression of u-PA. These findings may conduce to the elucidation of the anti-angiogenic mechanism of triptolide.
出处
《生物医学工程学杂志》
EI
CAS
CSCD
北大核心
2005年第4期778-781,共4页
Journal of Biomedical Engineering
基金
山东省教育厅资助课题(J01K08)
